Stelvio Therapeutics

Stelvio Therapeutics develops drugs to treat incurable cancers and neurodegenerative disease by driving diseased stems cells to non-diseased fates. Stelvio does this though a machine vision and learning platform that identifies drugs inducing epigenetic changes.

Be Part of the Revolution!

Next program starts Winter 2017. Applications due October 30th!